Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
RESEARCH TOOLSreports
Inhibikase Therapeutics (IKT) Stock Forecast & Price Target
89 Followers
See the Price Targets and Ratings of:
IKT Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IKT Stock 12 Month Forecast
Average Price Target
$17.50
▲(733.33% Upside)
| Highest Price Target$27.00 | Average Price Target$17.50 | Lowest Price Target$8.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
03/05/24
Best Analysts Covering Inhibikase Therapeutics
Which Analyst Should I Follow If I Want to Buy IKT and Sell After:
1 Month
3 Months
1 Year
Success Rate
2/7 ratings generated profit
Average Return
-1.93%
reiterated a buy rating 2 months ago
Copying Edward White's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -1.93% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IKT Analyst Recommendation Trends
Rating
Oct 23
Jan 24
Feb 24
Mar 24
Apr 24
Strong Buy
4
3
4
4
4
Buy
0
0
0
0
0
Hold
2
2
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
5
5
4
4
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
IKT Financial Forecast
IKT Stock Forecast FAQ
What is IKT’s average 12-month price target, according to analysts?
Based on analyst ratings, Inhibikase Therapeutics’s 12-month average price target is $17.50.
What is IKT’s upside potential, based on the analysts’ average price target?
Inhibikase Therapeutics has 733.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IKT a Buy, Sell or Hold?
Inhibikase Therapeutics has a conensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Inhibikase Therapeutics’s price target?
The average price target for Inhibikase Therapeutics is $17.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $27.00 ,the lowest forecast is $8.00. The average price target represents 733.33% Increase from the current price of $2.1.
The highest analyst price target is $27.00 ,the lowest forecast is $8.00. The average price target represents 733.33% Increase from the current price of $2.1.
What do analysts say about Inhibikase Therapeutics?
Inhibikase Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of IKT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.